CollPlant Biotechnologies Ltd.
CLGN
$2.71
$0.083.04%
NASDAQ
06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
---|---|---|---|---|---|
Net Income | -- | -- | -17.47M | -7.50M | |
Total Depreciation and Amortization | -- | -- | 1.10M | 1.10M | |
Total Amortization of Deferred Charges | -- | -- | -- | -- | |
Total Other Non-Cash Items | -- | -- | 2.03M | 1.93M | |
Change in Net Operating Assets | -- | -- | 11.60M | 1.91M | |
Cash from Operations | -- | -- | -2.75M | -2.57M | |
Capital Expenditure | -- | -- | -756.00K | -891.00K | |
Sale of Property, Plant, and Equipment | -- | -- | 68.00K | 68.00K | |
Cash Acquisitions | -- | -- | -- | -- | |
Divestitures | -- | -- | -- | -- | |
Other Investing Activities | -- | -- | -268.00K | -270.00K | |
Cash from Investing | -- | -- | -956.00K | -1.09M | |
Total Debt Issued | -- | -- | -- | -- | |
Total Debt Repaid | -- | -- | -- | -- | |
Issuance of Common Stock | -- | -- | 225.00K | 314.00K | |
Repurchase of Common Stock | -- | -- | -- | -- | |
Issuance of Preferred Stock | -- | -- | -- | -- | |
Repurchase of Preferred Stock | -- | -- | -- | -- | |
Total Dividends Paid | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | |
Cash from Financing | -- | -- | 225.00K | 314.00K | |
Foreign Exchange rate Adjustments | -- | -- | -176.00K | -220.00K | |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
Net Change in Cash | -- | -- | -3.66M | -3.57M | |